Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.97NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.1.1.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FE.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.3.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.95NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ET.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.34NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.56NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.59NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.67NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.2.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.5.88NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.1.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.80NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.134NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CZ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.2.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CW.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAY.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CH.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.46NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.71NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.445NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.21 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.199NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.112NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.123NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.143NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.29NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.48NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.46.6.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.112.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.360NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used